EMA says AstraZeneca COVID-19 vaccine is safe

AstraZeneca: Covid-19 vaccine “Safe, effective” should continue to be used by the European Medicines Agency announced today after review Concerns about blood clotting,

The agency said it could not rule out a link to two rare blood transfusion conditions seen in 25 people who received the vaccine. It added that warnings should be included with information about the vaccine provided to doctors և Patients. Nine of these people died.

The EU Pharmacological Risk Assessment Committee (PRAC) has been asked to review the safety of the AstraZeneca vaccine after more than 20 European countries, including Germany, France, Italy and Spain discontinued vaccinations from reports of rare thrombotic disorders

Germany, France, Italy and Spain all spoke out after the EMA announcement would resume using the AstraZeneca vaccine.

EMA chief executive Emer Cook told reporters on Thursday that the commission had found a reduction in overall blood counts compared to the general population of nearly 20 million people who have been vaccinated so far worldwide.

“The committee has come to a clear scientific conclusion,” he said. “This is a safe, effective vaccine.”

But PRAC President Sabina Strauss says experts have not been able to rule out a link to 18 contingent cases called cerebral venous sinus thrombosis (CVST) ոթ seven cases spread intravascular coagulation (DIC), both are associated with decreased platelet counts. In CVST, blood clots can prevent blood flow to the brain, leading to bleeding. DIC is a condition in which blood clots form in very small vessels in the body, which can lead to serious organ damage.

The EMA will continue to investigate these cases հնարավոր possible vaccine links. But Cook stressed that the benefits of the AstraZeneca vaccine in protecting people from COVID-19, which currently kills thousands of Europeans each week, outweigh the risk of overdose.

“Therefore, the committee proposed to raise awareness,” he said.

Some experts have suggested that condensation may be related to certain doses of the vaccine, but Strauss says the EMA does not support this theory. “PRAC has not found any evidence of quality or batch,” he said.

The White House on Thursday confirmed that the Biden administration would ship 2.5 million doses of the AstraZeneca vaccine to Mexico and 1.5 million to Canada. The shots will come from available domestic supplies awaiting FDA approval, which may come next month after a major U.S. vaccine test is completed.

The step follows in terms of dosage from Mexico earlier this week. Biden told reporters on Thursday that the United States was considering moving any overdose abroad after the end of domestic vaccinations. Peter Marx, a senior FDA official, told Congress on Wednesday that his agency had some concerns about exporting too many doses if the immunity to the vaccine was shortened and the US population needed a boost shot.

Others speculate that the AstraZeneca vaccine will cause more problems in the United States, as antioxidants have taken advantage of its spread.

“Does it really have room to fill in?” Will it be trusted enough? Or will it just be another headache? ” Earlier this week, John on Moore, a virologist at Weill Cornell Medical College in New York who is working on a vaccine, told BuzzFeed News.

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button